Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer.

ABSTRACT:

Background

Metronomic chemotherapy (MCT), termed sustained low-dose administration with minimal toxicity, is a new modality of conventional chemotherapy, a verified therapy alternative, and has acquired significant recognition and interest in oncology. Numerous clinical trials of MCT in combination with other treatments, including targeted therapies, biologics, and endocrine therapy, are in progress to obtain better results.

Summary

We comprehensively described the clinical benefits of MCT in combination with other treatments in different molecular subtypes of breast cancer and assessed the feasibility of its adoption in varying phases of treatment. Due to the promising preclinical and clinical investigations, it is expected that MCT in combination with other treatments will

SUBMITTER: Liu J 

PROVIDER: S-EPMC9677858 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature